The NHS-funded SBRI Healthcare innovation initiative has announced the companies that have reached the second phase of its competition.
Each company will receive further funding of up to £1 million to develop products specifically focused on addressing challenges in five key areas of healthcare: child and maternal health, integrated care, medicines adherence, musculoskeletal, and telehealth/telecare for people with learning disabilities.
From 26 companies awarded Phase 1 funding in December 2014, 11 have met the criteria of best value and greatest technical feasibility:
Companies receiving the latest SBRI Healthcare Phase 2 funding are:
- - Child & Maternal Health – BioSensors, Digital Creativity in Disability
- - Integrated Care – Bering, Docobo
- - Medicines Adherence – ADI, Folium Optics
- - Musculoskeletal – Armourgel, MIRA Rehab
- - Telehealth/Telecare for people with Learning Disabilities – RedEmbedded, Maldaba, Cupris Health
The initiative is funded by NHS England and run by England’s 15 Academic Health Science Networks (AHSNs). It aims to help develop innovative products that address unmet health needs.
Jon Siddall, director of investment partnerships at South West AHSN commented, “SBRI Healthcare is about us finding innovations that solve problems that we face in the NHS. Congratulations to all the companies who have been successful in securing further funding to develop their products – it is good news for them, but it is also very good news for the NHS. The ideas they are working on will directly benefit patients and the NHS as a whole, typically improving health and saving money by finding solutions that work better than what we are doing at the moment.”
In the last year, SBRI Healthcare has launched 10 new clinically-led competitions and awarded £22.4 million to 60 companies to develop products focused on specific NHS unmet need.